Innovent Biologics Inc (6IB) — Working Capital to Net Assets Ratio
Innovent Biologics Inc (6IB) has a Working Capital to Net Assets ratio of 70.4% as of December 2025. Working capital of €13.63 Billion (current assets of €22.01 Billion minus current liabilities of €8.39 Billion) is measured against net assets of €19.36 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Innovent Biologics Inc (6IB) net asset quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Innovent Biologics Inc Working Capital to Net Assets (2016–2025)
This chart shows how Innovent Biologics Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the ratio stands at 70.4%, reflecting working capital of €13.63 Billion against net assets of €19.36 Billion EUR. Check Innovent Biologics Inc (6IB) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Innovent Biologics Inc (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Innovent Biologics Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 6IB market cap overview.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 70.4% | €13.63 Billion | €19.36 Billion | €22.01 Billion | €8.39 Billion | ▲ +25.4 pp |
| 2024 | 45.0% | €5.90 Billion | €13.12 Billion | €10.27 Billion | €4.37 Billion | ▼ -26.4 pp |
| 2023 | 71.5% | €8.95 Billion | €12.53 Billion | €13.43 Billion | €4.48 Billion | ▼ -3.2 pp |
| 2022 | 74.6% | €8.01 Billion | €10.73 Billion | €11.51 Billion | €3.50 Billion | ▼ -7.7 pp |
| 2021 | 82.3% | €8.50 Billion | €10.33 Billion | €11.55 Billion | €3.05 Billion | ▼ -8.6 pp |
| 2020 | 90.9% | €7.98 Billion | €8.78 Billion | €9.47 Billion | €1.49 Billion | ▼ -1.9 pp |
| 2019 | 92.8% | €4.41 Billion | €4.76 Billion | €5.46 Billion | €1.04 Billion | ▼ -3.0 pp |
| 2018 | 95.7% | €4.02 Billion | €4.19 Billion | €4.69 Billion | €670.32 Million | ▲ +174.8 pp |
| 2017 | -79.1% | €1.28 Billion | €-1.62 Billion | €1.45 Billion | €163.28 Million | ▲ +108.2 pp |
| 2016 | -187.3% | €1.79 Billion | €-958.22 Million | €1.87 Billion | €76.20 Million | — |